Cargando…

The Immunomodulatory Role of Microbiota in Rheumatic Heart Disease: What Do We Know and What Can We Learn from Other Rheumatic Diseases?

Rheumatic heart disease (RHD) represents a serious cardiac sequela of acute rheumatic fever, occurring in 30–45% of patients. RHD is multifactorial, with a strong familial predisposition and known environmental risk factors that drive loss of immunological tolerance. The gut and oral microbiome have...

Descripción completa

Detalles Bibliográficos
Autores principales:	Kohil, Amira, Abdalla, Wafa, Ibrahim, Wisam N., Al-Harbi, Khalid M., Al-Haidose, Amal, Al-Asmakh, Maha, Abdallah, Atiyeh M.
Formato:	Online Artículo Texto
Lenguaje:	English
Publicado:	MDPI 2023
Materias:	Review
Acceso en línea:	https://www.ncbi.nlm.nih.gov/pmc/articles/PMC10536446/ https://www.ncbi.nlm.nih.gov/pubmed/37763748 http://dx.doi.org/10.3390/medicina59091629

Ejemplares similares

Exercise, infection and rheumatic diseases: what do we know?
por: Calabrese, Leonard, et al.
Publicado: (2021)

The Impact of ACE Gene Variants on Acute-Phase Reactants in Children with Rheumatic Heart Disease
por: Almazroea, Abdulhadi H., et al.
Publicado: (2023)

COVID-19 and cardiovascular disease: What we know, what we think we know, and what we need to know
por: Dhawan, Rahul, et al.
Publicado: (2020)

Peri-implant disease: what we know and what we need to know
por: Valente, Nicola Alberto, et al.
Publicado: (2016)

The origin of life: what we know, what we can know and what we will never know
por: Pross, Addy, et al.
Publicado: (2013)

Quasicrystals: What do we know? What do we want to know? What can we know?
por: Steurer, Walter
Publicado: (2018)

Investigating emotions in Parkinson's disease: what we know and what we still don't know
por: Sotgiu, Igor, et al.
Publicado: (2013)

The Etiology and Pathology of Dental Diseases: What We Know, and What We Would like to Know
por: Sewill, Henry
Publicado: (1882)

International Trade and Investment and Food Systems: What We Know, What We Don’t Know, and What We Don’t Know We Don’t Know
por: Schram, Ashley, et al.
Publicado: (2020)

Cardiac surgery and the coronavirus disease 2019 pandemic: What we know, what we do not know, and what we need to do
por: Bakaeen, Faisal G., et al.
Publicado: (2020)

“Tau Oligomers,” What We Know and What We Don’t Know
por: Sahara, Naruhiko, et al.
Publicado: (2014)

Epigenetics in Schistosomes: What We Know and What We Need Know
por: Liu, Weiwei
Publicado: (2016)

Portion Size: What We Know and What We Need to Know
por: Benton, David
Publicado: (2015)

Paediatric schistosomiasis: What we know and what we need to know
por: Osakunor, Derick N. M., et al.
Publicado: (2018)

Immunotherapy and fatigue: what we know and what we don’t know
por: Azeem Khan, Muhammad, et al.
Publicado: (2021)

Vaginal Aging—What We Know and What We Do Not Know
por: Szymański, Jacek K., et al.
Publicado: (2021)

Metabolic syndrome: what we know and what we need to know
por: Soares, Raquel
Publicado: (2020)

The Coming-of-Age Transition Care for Adolescents with Rheumatic Disease—Where Are We and What Have We Done in Asia?
por: Teh, Kai Liang, et al.
Publicado: (2021)

Echocardiography Screening for Latent Rheumatic Heart Disease: What Can We Do in Indonesia?
por: Soesanto, Amiliana M., et al.
Publicado: (2020)

Impact of MIF Gene Promoter Variations on Risk of Rheumatic Heart Disease and Its Age of Onset in Saudi Arabian Patients
por: Abdallah, Atiyeh M., et al.
Publicado: (2016)

Incontinentia pigmenti: What we know and can we manage it as retinopathy of prematurity?
por: Al-Farsi, Nouf, et al.
Publicado: (2022)

Complement and COVID-19: Three years on, what we know, what we don't know, and what we ought to know
por: Zelek, Wioleta M., et al.
Publicado: (2023)

The Interplay Between Diet and the Epigenome in the Pathogenesis of Type-1 Diabetes
por: Kohil, Amira, et al.
Publicado: (2021)

Angiotensin-converting enzyme gene insertion/deletion polymorphism in Saudi patients with rheumatic heart disease
por: Al-Harbi, Khalid M., et al.
Publicado: (2015)

Cutaneous Adnexal Cysts Revisited: What We Know and What We Think We Know
por: Kaya, Gürkan, et al.
Publicado: (2018)

Commentary: Is this a case in which we know what we don't know what we don't know?
por: Nantsios, Alex, et al.
Publicado: (2021)

Nephrotoxicity testing in vitro--what we know and what we need to know.
por: Pfaller, W, et al.
Publicado: (1998)

Asthma in the elderly: what we know and what we have yet to know
por: Yáñez, Anahí, et al.
Publicado: (2014)

What We Know and What We Don't Know About Preventing Stroke
por: Burch, Druin
Publicado: (2014)

Contagious itch: what we know and what we would like to know
por: Schut, C., et al.
Publicado: (2015)

Goal-directed therapy: what we know and what we need to know
por: O’Neal, Jason B, et al.
Publicado: (2015)

Transmission of Ebola Viruses: What We Know and What We Do Not Know
por: Osterholm, Michael T., et al.
Publicado: (2015)

Human Extraintestinal Sarcocystosis: What We Know, and What We don’t Know
por: Harris, V. C., et al.
Publicado: (2015)

Membrane fission by dynamin: what we know and what we need to know
por: Antonny, Bruno, et al.
Publicado: (2016)

Microplastics in freshwater ecosystems: what we know and what we need to know
por: Wagner, Martin, et al.
Publicado: (2014)

Pneumonia in Bhutanese children: what we know, and what we need to know
por: Jullien, Sophie, et al.
Publicado: (2020)

Impacts of Neonicotinoids on Molluscs: What We Know and What We Need to Know
por: Ewere, Endurance E, et al.
Publicado: (2021)

COVID-19 in Children: What We Know and What We Don’t Know?
por: Jat, Kana Ram
Publicado: (2021)

Presbyopia: What We Do Know and What We Do Not Know in 2022
por: Grzybowski, Andrzej, et al.
Publicado: (2023)

Hepatitis E Virus and rheumatic diseases: what do rheumatologists need to know?
por: Di Bartolomeo, Salvatore, et al.
Publicado: (2020)

Cannot write session to /tmp/vufind_sessions/sess_260jl9lnfhidntla192tbl5kl9